Alberto Rubio-Casillas
Overview
Explore the profile of Alberto Rubio-Casillas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adilovic M, Hromic-Jahjefendic A, Mahmutovic L, Sutkovic J, Rubio-Casillas A, Redwan E, et al.
J Cell Biochem
. 2024 Dec;
126(1):e30683.
PMID: 39639607
The complex link between COVID-19 and immunometabolic diseases demonstrates the important interaction between metabolic dysfunction and immunological response during viral infections. Severe COVID-19, defined by a hyperinflammatory state, is greatly...
2.
El-Maradny Y, Badawy M, Mohamed K, Ragab R, Moharm H, Abdallah N, et al.
Int J Biol Macromol
. 2024 Aug;
279(Pt 2):135201.
PMID: 39216563
Background: The nucleocapsid protein (N protein) is the most abundant protein in SARS-CoV-2. Viral RNA and this protein are bound by electrostatic forces, forming cytoplasmic helical structures known as nucleocapsids....
3.
Hromic-Jahjefendic A, Mahmutovic L, Sezer A, Becirevic T, Rubio-Casillas A, Redwan E, et al.
Cytokine Growth Factor Rev
. 2024 Aug;
82:43-54.
PMID: 39179487
Long COVID-19 affects a significant percentage of patients and is characterized by a wide range of symptoms, including weariness and mental fog as well as emotional symptoms like worry and...
4.
Rubio-Casillas A, Cowley D, Raszek M, Uversky V, Redwan E
Int J Biol Macromol
. 2024 May;
270(Pt 2):132447.
PMID: 38762995
No abstract available.
5.
Golzardi M, Hromic-Jahjefendic A, Sutkovic J, Aydin O, Unal-Aydin P, Becirevic T, et al.
Biomedicines
. 2024 Apr;
12(4).
PMID: 38672267
Background: Post-acute sequelae of SARS-CoV-2 infection (PASC) is a complicated disease that affects millions of people all over the world. Previous studies have shown that PASC impacts 10% of SARS-CoV-2...
6.
Rubio-Casillas A, Cowley D, Raszek M, Uversky V, Redwan E
Int J Biol Macromol
. 2024 Apr;
267(Pt 1):131427.
PMID: 38583833
Due to the health emergency created by SARS-CoV-2, the virus that causes the COVID-19 disease, the rapid implementation of a new vaccine technology was necessary. mRNA vaccines, being one of...
7.
Eltayeb A, Al-Sarraj F, Alharbi M, Albiheyri R, Mattar E, Abu Zeid I, et al.
J Cell Biochem
. 2024 Feb;
125(3):e30530.
PMID: 38349116
When the SARS-CoV-2 virus infects humans, it leads to a condition called COVID-19 that has a wide spectrum of clinical manifestations, from no symptoms to acute respiratory distress syndrome. The...
8.
Rubio-Casillas A, Rodriguez-Quintero C, Redwan E, Gupta M, Uversky V, Raszek M
Vaccine
. 2023 Dec;
42(3):426-440.
PMID: 38158298
Contrary to the long-held belief that the effects of vaccines are specific for the disease they were created; compelling evidence has demonstrated that vaccines can exert positive or deleterious non-specific...
9.
El-Maradny Y, Rubio-Casillas A, Mohamed K, Uversky V, Redwan E
J Cell Biochem
. 2023 Oct;
124(10):1466-1485.
PMID: 37801299
With the decline in the number of new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections, the World Health Organization announced the end of the SARS-CoV-2 pandemic. However, the repercussions...
10.
Rubio-Casillas A, Redwan E, Uversky V
Biomolecules
. 2023 Sep;
13(9).
PMID: 37759738
SARS-CoV-2, the virus that causes the COVID-19 disease, has been shown to cause immune suppression in certain individuals. This can manifest as a reduced ability of the host's immune system...